Bayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer. by Alyssa Navarro
Healthy Living/Wellness Study Raises Safety Concern About Bayer Sterilization Device: Essure Tied With Increased Need For Reoperations by Julienne Roman
Healthy Living/Wellness Reports Of Health Complications Prompt FDA To Review Safety Of Essure Birth Control Implant by Julienne Roman
Healthy Living/Wellness Bayer Pushes Heart Failure Drug Finerenone To Final-Stage Trials by Rina Marie Doctor
Healthy Living/Wellness Court awards Chicago woman $14 mn in damages after taking wrongly prescribed Yasmin contraceptive by Rhodi Lee
Healthy Living/Wellness Prostate cancer drug Xofigo not recommended by British authorities due to cost effectiveness issues by Lori Sandoval